IMO there is plenty of private equity looking for post-covid, growth opportunities. With the added benefits of 'green'/decarbonisation advancements and bluesky, ADN presents an appealing case with minimal debt funding in a tier-1 jurisdiction with a very low risk of achieving cash-flow positive territory.
Agree that international funds may be desirable, but not sure that int. market scrip is the way to go.
IMO there is plenty of private equity looking for post-covid,...
Add ADN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $24.00M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.6¢ | $191.3K | 27.36M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 16312290 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 11037979 | 13 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| ADN (ASX) Chart |